Martin Hils

5PUBLICATIONS
10CO-AUTHORS
Agricultural molecular engineering of nucleic acids and proteinsAgricultural biotechnology diagnostics (incl. biosensors)Proteins and peptidesFood sciences not elsewhere classifiedApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 24, 2024
Transcriptomic analysis of intestine following administration of a transglutaminase 2 inhibitor to prevent gluten-induced intestinal damage in celiac disease.

Valeriia Dotsenko, Bernhard Tewes, Martin Hils

|Jul 14, 2023
The Oral Transglutaminase 2 Inhibitor ZED1227 Accumulates in the Villous Enterocytes in Celiac Disease Patients during Gluten Challenge and Drug Treatment.

Jorma Isola, Markku Mäki, Martin Hils

|May 28, 2022
Features of ZED1227: The First-In-Class Tissue Transglutaminase Inhibitor Undergoing Clinical Evaluation for the Treatment of Celiac Disease.

Christian Büchold, Martin Hils, Uwe Gerlach

|Dec 28, 2017
Response to Comment by Calderón de la Barca and Sigala-Robles on Microbial Transglutaminase Used in Bread Preparation at Standard Bakery Concentrations Does Not Increase Immunodetectable Amounts of Deamidated Gliadin.

Andreas Heil, Keiichi Yokoyama, Yoshiyuki Kumazawa

|Jul 20, 2017
Microbial Transglutaminase Used in Bread Preparation at Standard Bakery Concentrations Does Not Increase Immunodetectable Amounts of Deamidated Gliadin.

Andreas Heil, Jürgen Ohsam, Bernard van Genugten

Pageof 1

Frequent Collaborators

2 joint publications

Andreas Heil

2 joint publications

Jorma Isola

2 joint publications

Keijo Viiri

1 joint publications

Daniel Aeschlimann